XML 35 R11.htm IDEA: XBRL DOCUMENT
v3.25.3

Trade Receivables | 9 Months Ended
--- | ---
Sep. 30, 2025
Receivables [Abstract] |
Trade Receivables | Trade Receivables Product Sales Receivables from product sales are recorded for amounts due to the Company related to sales of ORLADEYO and peramivir. At September 30, 2025 and December 31, 2024, receivables, net of reserves, related to sales of ORLADEYO were $88,034 and $76,282, respectively. At September 30, 2025 and December 31, 2024, receivables related to sales of peramivir were $153 and $564, respectively. At September 30, 2025, there was $10,285 of accounts receivable, net of reserves, included in current assets held for sale. See “Note 2—Assets and Liabilities Held for Sale” for further details. Collaborative and Other Revenue At September 30, 2025 and December 31, 2024 receivables from the Company’s royalty partners were $3,138 and $2,223, respectively.

X
- Definition The entire disclosure for trade receivables. + References No definition available. + Details
Name: | bcrx_TradeReceivablesTextBlock
Namespace Prefix: | bcrx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration